C0717537_interactsWith_C0014695 | Knowledge4COVID-19

Property	Value
?:effect	<https://research.tib.eu/covid-19/entity/C0001688>
?:hasPrimarySource	<https://research.tib.eu/covid-19/SourceName/UMLS>
?:impact	increase
?:interaction	The risk or severity of adverse effects can be increased when Calcium acetate is combined with Ergocalciferol. The risk or severity of adverse effects can be increased when Calcium acetate is combined with Vitamin D.
?:objectDrug	<https://research.tib.eu/covid-19/entity/C0014695>
?:object_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB00153> <https://research.tib.eu/covid-19/entity/DB11094>
?:precipitantDrug	<https://research.tib.eu/covid-19/entity/C0717537>
?:precipitant_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB00258>
is ?:subClassOf of	<https://research.tib.eu/covid-19/entity/C0717537_hasPharmacodynamic_C0014695>
?:type	<https://research.tib.eu/covid-19/vocab/DrugDrugInteraction>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C0717537_interactsWith_C0014695>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C0717537_interactsWith_C0014695>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all